Wayland Rushing

About Wayland Rushing

Dr. Wayland Rushing is a technical expert in Chemistry Manufacturing and Controls (CMC) program design, analytical development and regulatory submissions. Over his career, he has led CMC development programs for a wide array of pharmaceutical products, including parenterals, inhalation drugs, drug/device combinations and other therapies with complex delivery systems. Dr. Rushing is a subject matter expert in HPLC and GC method development and validation, extractables and leachables program design and regulatory submission requirements; has drafted multiple IND and NDA submissions; and assists ABC clients in responding to FDA deficiency letters. Dr. Rushing is a co-author of PDA Tech Report # 65, Technology Transfer and Tech Report # 76 on Identification and Classification of Visible Nonconformities in Elastomeric Components and Aluminum Seals for Parenteral Packaging

Experience

1. General Manager & Site Head

   Curia

   Apr 2025 — Present · Springfield, MO, US

Education

• University of Missouri-Columbia

  Doctor of Philosophy (Ph.D.), Chemistry

  1995 — 2000

• Westminster University

  BA, Chemistry

  1991 — 1995

Skills

• Validation
• Biotechnology
• Life Sciences
• Pharmaceutical Industry
• Fda
• Chromatography
• Chemistry
• Regulatory Affairs
• Lifesciences
• Gmp
• CRO
• Drug Development
• Biopharmaceuticals
• Pharmaceutics
• Drug Discovery
• Good Laboratory Practice (Glp)
• Glp
• Analytical Chemistry
• Hplc
• Organic Chemistry
• Clinical Development
• CRO Management
• Technology Transfer